TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
2,177
|
2,504
|
2,064 |
| Financial expenses |
26
|
2
|
1 |
| Earnings before taxes |
117
|
403
|
4 |
| Total assets |
1,167
|
1,075
|
811 |
| Current assets |
1,166
|
1,074
|
811 |
| Current liabilities |
444
|
408
|
443 |
| Equity capital |
722
|
667
|
368 |
| - share capital |
39
|
41
|
39 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
61.9%
|
62.0%
|
45.4% |
| Turnover per employee |
1,088
|
1,252
|
1,032 |
| Profit as a percentage of turnover |
5.4%
|
16.1%
|
0.2% |
| Return on assets (ROA) |
12.3%
|
37.7%
|
0.6% |
| Current ratio |
262.6%
|
263.2%
|
183.1% |
| Return on equity (ROE) |
16.2%
|
60.4%
|
1.1% |
| Change turnover |
-196
|
328
|
366 |
| Change turnover % |
-8%
|
15%
|
22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.